Acamprosate for the treatment of alcohol use disorder may be safer than baclofen in patients with cirrhosis

被引：0
|
作者：
Tyson, Luke D. [1 ,2 ]
Cheng, Alexandra [2 ]
Kelleher, Charles [2 ]
Strathie, Kirstin [2 ]
Lovendoski, James [2 ]
Habtemariam, Zebib [2 ]
Lewis, Heather [2 ]
机构：
[1] Imperial Coll London, Dept Metab Digest & Reprod, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Hepatol, London, England
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-607
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 50 条
  • [1] Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice
    Tyson, Luke David
    Cheng, Alexandra
    Kelleher, Charles
    Strathie, Kirstin
    Lovendoski, James
    Habtemariam, Zebib
    Lewis, Heather
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 567 - 575
  • [2] Acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?
    Giri, Suprabhat
    Sundaram, Sridhar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (06) : 724 - 724
  • [3] Response to 'acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?'
    Tyson, Luke D.
    Lewis, Heather
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (09) : 976 - 976
  • [4] Naltrexone May Attenuate the Effect of Acamprosate in Patients With Alcohol Use Disorder and Major Depressive Disorder
    Ou, Hsun
    Chen, Chun-Yen
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (06) : E580 - E581
  • [5] Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence
    Mosoni, Carolina
    Dionisi, Tommaso
    Vassallo, Gabriele Angelo
    Mirijello, Antonio
    Tarli, Claudia
    Antonelli, Mariangela
    Sestito, Luisa
    Rando, Maria Margherita
    Tosoni, Alberto
    De Cosmo, Salvatore
    Gasbarrini, Antonio
    Addolorato, Giovanni
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [6] Editorial: Baclofen in the Treatment of Alcohol Use Disorder
    de Beaurepaire, Renaud
    Heydtmann, Mathis
    Agabio, Roberta
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [7] ALCOHOL USE DISORDER TREATMENT AND SUBSEQUENT MORTALITY AMONG PATIENTS WITH CIRRHOSIS AND ALCOHOL USE DISORDER
    Alexandre, Wheytnie
    Haseeb, Muhammad
    Agbalajobi, Olufunso M.
    Zhang, Grace Yuan
    Jonassaint, Naudia L.
    Bataller, Ramon
    Rogal, Shari S.
    HEPATOLOGY, 2020, 72 : 150A - 151A
  • [8] Baclofen for the treatment of alcohol use disorder: the Cagliari Statement
    Agabio, Roberta
    Sinclair, Julia M. A.
    Addolorato, Giovanni
    Aubin, Henri-Jean
    Beraha, Esther M.
    Caputo, Fabio
    Chick, Jonathan D.
    de La Selle, Patrick
    Franchitto, Nicolas
    Garbutt, James C.
    Haber, Paul S.
    Heydtmann, Mathis
    Jaury, Philippe
    Lingford-Hughes, Anne R.
    Morley, Kirsten C.
    Mueller, Christian A.
    Owens, Lynn
    Pastor, Adam
    Paterson, Louise M.
    Pelissier, Fanny
    Rolland, Benjamin
    Stafford, Amanda
    Thompson, Andrew
    van den Brink, Wim
    de Beaurepaire, Renaud
    Leggio, Lorenzo
    LANCET PSYCHIATRY, 2018, 5 (12): : 957 - 960
  • [9] Incorporating ondansetron and baclofen in alcohol use disorder treatment
    Ross, Hayley
    Harries, Bruce
    Szelest, Izabela
    Engelbrecht, Roland
    Umhau, John C.
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2023, 25 (03) : 253 - 254
  • [10] Incorporating ondansetron and baclofen in alcohol use disorder treatment
    Hayley Ross
    Bruce Harries
    Izabela Szelest
    Roland Engelbrecht
    John C. Umhau
    Canadian Journal of Emergency Medicine, 2023, 25 : 253 - 254
12345